Preclinical Research Solution
Provider for Neoantigen

Alfa Cytology is a leading scientific partner specializing in tumor neoantigen
discovery and characterization. We empower cancer researchers and therapeutic
developers with cutting-edge solutions.

About Alfa Cytology

Alfa Cytology is committed to driving transformative progress in cancer immunotherapy through scientifically rigorous, clinically meaningful neoantigen research.

  • Accelerate neoantigen identification and validation
  • Advance personalized immunotherapy development
  • Bridge translational gaps in oncology research

Biomarker Discovery

Alfa Cytology provides discovery services for tumor biomarkers, which are molecules, genes, or proteins that reflect information about the presence, progression, and efficacy of tumors, and have important applications in cancer diagnosis, treatment, and prognosis.

Biomarker Services

Alfa Cytology offers services for the discovery of different types of cancer biomarkers and the application development of corresponding diagnostic methods, diagnostic reagents and therapeutic strategies according to the research needs of our clients.

Cancer Type We Study

Based on our well-established technology platform for tumor biomarker research, we focus on a variety types of cancer biomarker research.